Physician profile
William D Dedman
NPI 1750342804
$989.31
in general payments reported to CMS, 2019-2025
16 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.54 · 2020: $11.95 · 2021: $20.11 · 2022: $114 · 2023: $379 · 2024: $249 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $173.35 | 2022-2024 | Trelegy Ellipta |
| Abbvie INC. | $169.22 | 2022-2025 | Vraylar, Qulipta |
| Lilly USA, LLC | $105.03 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $102.63 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $92.77 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $63.19 | 2022-2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $52.03 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $51.94 | 2022-2024 | Rotateq, Capvaxive, Gardasil |
| Novo Nordisk INC | $51.21 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.09 | 2025 | Caplyta |
| Cardiovascular Systems INC. | $20.54 | 2019 | |
| Boston Scientific Corporation | $20.11 | 2021 | |
| Dexcom, INC. | $19.86 | 2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $16.63 | 2024 | Voquezna |
| Shield Therapeutics INC | $14.76 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.